These Healthcare stocks are trading higher:
-Zogenix, Inc. (ZGNX) stock is trading at $25.97, a gain of $10.33, or 66.1%, on high volume. Zogenix Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $33.00. Zogenix Inc next reports earnings on February 2.
-Vivos Therapeutics Inc (VVOS) stock is trading at $2.21, a rise of $0.58, or 35.89%, on high volume. Vivos Therapeutics Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $9.75. Vivos Therapeutics Inc next reports earnings on February 13.
-Valneva SE ADR (VALN) stock is trading at $44.09, a rise of $11.32, or 34.54%, on high volume. Valneva Se ADR gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $52.50.
-G Medical Innovations Holdings Ltd (GMVD) stock is trading at $5.54, a rise of $1.33, or 32.54%, on high volume. G Medical Innovations Holdings L gets a Sentiment Score of Bullish from InvestorsObserver.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Cardiff Oncology Inc (CRDF) stock is trading at $4.75, a decline of $1.39, or 22.15%, on high volume. Cardiff Oncology Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $23.75. Cardiff Oncology Inc next reports earnings on February 2.-OncoCyte Corp (OCX) stock is trading at $1.74, a drop of $0.46, or 20.78%, on high volume. Oncocyte Corp gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.84. Oncocyte Corp next reports earnings on February 7.
-Petros Pharmaceuticals Inc (PTPI) stock is trading at $1.86, a decline of $0.46, or 19.87%, on low volume. Petros Pharmaceuticals Inc gets a Sentiment Score of Very Bearish from InvestorsObserver.
-Yumanity Therapeutics Inc (YMTX) stock is trading at $2.03, a decline of $0.42, or 17.35%, on high volume. Yumanity Therapeutics Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $27.67. Yumanity Therapeutics Inc next reports earnings on February 13.